Stratified analysis | No. of trials | No. of patientsa | Risk ratio (95% CI) SMD (95% CI) | p value | I 2 (p value) |
---|---|---|---|---|---|
In-hospital mortality | |||||
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 5 | 404 | 0.83 (0.62–1.11) | 0.20 | 0% (0.57) |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 5 | 399 | 0.82 (0.62–1.09) | 0.17 | 0% (0.73) |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 Versus <10 cmH2O | 3 | 131 | 2.04 (0.19–21.85) | 0.56 | 77% (0.04) |
28-Day mortality | Â | Â | Â | Â | Â |
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 1 | 63 | 0.82 (0.47–1.45) | 0.50 | NA |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 2 | 183 | 0.55 (0.26–1.18) | 0.12 | 76% (0.04) |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 1 | 120 | 0.38 (0.24–0.62) | <0.001 | NA |
Duration of ventilation | |||||
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 2 | 87 | 0.89 (−0.95–2.73) | 0.34 | 91% (< 0.01) |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 2 | 101 | 0.17 (−0.25–0.60) | 0.43 | 13% (0.28) |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 1 | 38 | 0.45 (−0.20–1.09) | 0.18 | NA |
ARDS | Â | Â | Â | Â | Â |
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 4 | 410 | 0.43 (0.21–0.91) | 0.03 | 56% (0.08) |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 3 | 298 | 0.52 (0.27–1.02) | 0.06 | 50% (0.13) |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 0 | 0 | NA | NA | NA |
Pneumonia | Â | Â | Â | Â | Â |
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 3 | 331 | 0.58 (0.29–1.15) | 0.12 | 58% (0.09) |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 2 | 219 | 0.64 (0.24–1.66) | 0.36 | 72% (0.06) |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 0 | 0 | NA | NA | NA |
Atelectasis | Â | Â | Â | Â | Â |
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 3 | 331 | 0.74 (0.33–1.66) | 0.46 | 74% (0.02) |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 2 | 219 | 1.00 (0.54–1.84) | 0.99 | 63% (0.10) |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 0 | 0 | NA | NA | NA |
Barotrauma | Â | Â | Â | Â | Â |
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 4 | 374 | 0.60 (0.13–2.70) | 0.50 | 52% (0.15) |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 3 | 257 | 0.79 (0.28–2.27) | 0.67 | 22% (0.28) |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 4 | 203 | 6.26 (0.78–50.47) | 0.09 | 0% (0.46) |
PaO 2 /FiO 2 ratio | Â | Â | Â | Â | Â |
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 2 | 143 | 0.63 (0.29–0.96) | < 0.01 | 0% (0.79) |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 2 | 247 | 1.17 (0.06–2.28) | 0.04 | 94% (< 0.01) |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 4 | 253 | 0.74 (−0.14–1.61) | 0.10 | 89% (< 0.01) |
Hypoxemia | Â | Â | Â | Â | Â |
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 2 | 170 | 0.42 (0.19–0.92) | 0.03 | 19% (0.27) |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 1 | 127 | 0.35 (0.20–0.61) | < 0.01 | NA |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 1 | 43 | 1.05 (0.16–6.77) | 0.96 | NA |
Blood pressure | Â | Â | Â | Â | Â |
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | NA | NA | NA | NA | NA |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 1 | 120 | −0.92 (−1.30 to –0.54) | < 0.01 | NA |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 2 | 158 | −0.21 (−1.68 to 1.26) | 0.78 | 92% (< 0.01) |
Hypotension | Â | Â | Â | Â | Â |
Level of PEEP | Â | Â | Â | Â | Â |
 High PEEP versus ZEEP | 1 | 63 | 1.10 (0.68–1.79) | 0.70 | NA |
Type of patient | Â | Â | Â | Â | Â |
 Medical patients | 1 | 63 | 1.10 (0.68–1.79) | 0.70 | NA |
Level of PEEP | Â | Â | Â | Â | Â |
 ≥10 versus <10 cmH2O | 1 | 82 | 32.16 (2.04–507.16) | 0.01 | NA |